The timeline of the case was illustrated in Figure 2
If retatrutide dramatically improves insulin sensitivity (which the clinical data strongly suggests it does), the long-term net effect on hair might actually be positive for individuals whose prior hair thinning was driven by metabolic dysfunction
Purity: 99.40% CAS No.: 1639014-72-4 Formula: C 21 H 19 ClF 3 N 5 O 2 Molecular Weight:465.86 Storage:Powder -20C, 3 years , 4C, 2 years
However, FAERS has well-known limitations: Reports are spontaneous and incomplete Reporting stimulated by media attention and warnings No denominator (unknown number of exposed users) Thyroid cancer not subtype-adjudicated Confirmation bias (clinicians primed to connect drug and outcome) FAERS can answer: "Is this being reported more?" It cannot answer: "Does this drug cause thyroid cancer?" Appropriate Use of FAERS: FAERS findings are hypothesis-generating signals requiring controlled observational worknot evidence of causality
At this concentration, 0.1mL (10 units) contains 500mcg total peptide (250mcg each), and a 200mcg + 200mcg dose requires 0.08mL (8 units) easily measurable on standard U-100 syringes without fractional unit guesswork
Farnesyltransferase is an enzyme for farnesylation on the cysteine residue of the CAAX motif region of cytosolic RAS protein, resulting in RAS protein association with cellular membranes
